Home / Import refusals / AEK-0531016-2/41/1

FDA Import Refusal AEK-0531016-2/41/1 — GLAXO SMITH KLINE

GLAXO SMITH KLINE — FEI 3017162152

The FDA refused shipment AEK-0531016-2/41/1 from GLAXO SMITH KLINE (Indonesia) on March 8, 2022. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 8, 2022
Country
Indonesia
Product Category
Drugs and Biologics
Product Code
62GCJ18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
Charges
75

Other import refusals

  • 799-2883527-7/40002/1 (Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4615061-6/10002/1 (Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-6306527-8/41/1 (Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-1238642-4/11/3 (Thu May 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0809054-8/11/1 (Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources